These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

705 related items for PubMed ID: 12397878

  • 1. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL, Taylor WH, Ware MR.
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [Abstract] [Full Text] [Related]

  • 2. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].
    Hanel RA, Sandmann MC, Kranich M, De Bittencourt PR.
    Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine induced neuroleptic malignant syndrome--a case review.
    Kogoj A, Velikonja I.
    Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Atypical neuroleptic malignant syndrome associated with olanzapine.
    Reeves RR, Torres RA, Liberto V, Hart RH.
    Pharmacotherapy; 2002 May; 22(5):641-4. PubMed ID: 12013364
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
    Järventausta K, Leinonen E.
    Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
    [Abstract] [Full Text] [Related]

  • 9. Neuroleptic malignant syndrome associated with olanzapine.
    Johnson V, Bruxner G.
    Aust N Z J Psychiatry; 1998 Dec; 32(6):884-6. PubMed ID: 10084355
    [Abstract] [Full Text] [Related]

  • 10. Neuroleptic malignant syndrome associated with olanzapine.
    Filice GA, McDougall BC, Ercan-Fang N, Billington CJ.
    Ann Pharmacother; 1998 Nov; 32(11):1158-9. PubMed ID: 9825080
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Life threatening neuroleptic malignant syndrome due to olanzapine].
    Kopf A, Köster J, Schulz A, Krömker H, Becker T.
    Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
    [Abstract] [Full Text] [Related]

  • 13. Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy.
    Berry N, Pradhan S, Sagar R, Gupta SK.
    Pharmacotherapy; 2003 Feb; 23(2):255-9. PubMed ID: 12587815
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Atypical neuroleptic malignant syndrome caused by olanzapine.
    Nielsen J, Bruhn AM.
    Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
    Perry PJ, Wilborn CA.
    Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
    [Abstract] [Full Text] [Related]

  • 20. [Neuroleptic malignant syndrome. Case reports].
    Berardi D, Troia M, Veronesi L, Ferrari G.
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.